Navigation Links
27th Annual FSHD International Research Congress Goes Virtual

The FSHD Society announced the opening today of its 27th annual International Research Congress (IRC), which is being conducted entirely online for the first time in the organization’s history. The conference is widely seen as the premier global platform for the discussion and dissemination of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). A record 210 researchers, clinicians, industry representatives and patient advocates are attending.

“Due to the global COVID-19 crisis, we have deployed a robust virtual conference platform for the 2020 IRC which has opened the opportunity to participate for many researchers who previously could not afford the time or cost of travel,” noted Jamshid Arjomand, PhD, chief science officer of the Society.

Researchers who have convened at this gathering since 1994 have helped drive fundamental discoveries, arriving at a broad consensus on a central hypothesis of the genetic basis of FSHD, development of cellular and animal models, identification of multiple therapeutic targets, and the validation of clinical outcome measures. These fundamental discoveries and collaborations have advanced the field, prompting observational and clinical studies – including an ongoing Phase 2b clinical trial for the first disease-modifying therapy for FSHD as well as a large natural history study called ReSOLVE. These studies, as well as other clinical research, have responded to the challenges of collecting data while keeping volunteers safe during the COVID-19 pandemic.

The program committee made special efforts to attract clinical and industry researchers, as advancement of drug development brings greater urgency to improving the understanding of the clinical features of FSHD, genotype-phenotype correlations, natural history, and evaluation of disease progression. As a result, the number of attendees and scientific presentations has nearly doubled over the past two years.

A growing number of companies have elected to sponsor the FSHD International Research Congress as they enter the field of FSHD diagnostics and therapy development. This year’s foundation and industry supporters include: Association Français Contre les Myopathies, Avidity, Bionano, Dyne Therapeutics, Fulcrum Therapeutics, Genomic Vision, miRecule, Muscular Dystrophy Association, National Institutes of Health, PerkinElmer Genomics, and the University of Nevada Reno.

“With the recent advances in FSHD studies now including large sets of data, greater availability of biomaterials from multiple large research initiatives, and the rapid approach of more clinical trials,” the program committee stated. “The FSHD International Research Congress serves a more important role than ever: to ensure dissemination of the latest ideas and discussion of the field’s needs and priorities, combined with collaboration and coordination, to speed up progress toward delivering effective treatments to our patients and families.”

About the FSHD Society
The FSHD Society is the world’s largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy. The Society has catalyzed major advancements and is accelerating the development of treatments and a cure to end the pain, disability, and suffering endured by one million people worldwide who live with FSHD. The FSHD Society has transformed the landscape for FSHD research and is committed to making sure that no one faces this disease alone. The Society offers a community of support, news, and information through its website at

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Move United’s Annual Leadership Conference Goes Virtual
2. CISCRP Announces 2nd Annual Virtual Fitness Challenge to Recognize Medical Heroes
3. Phoenix Foundation of Maryland 2nd Annual Recovery Education Classic Golf Tournament
4. Shady Grove Fertility’s (SGF) Joseph Doyle, M.D., to Speak at Third Annual Canadian Fertility Show to Discuss the Advantages of Seeking Donor Egg Treatment in America
5. Distinguished Speaker to Discuss the Intersection of Privacy and Security Laws and Biometrics at the 3rd Annual Healthcare Compliance Symposium on April 23rd, 2020
6. Reach Higher and Collegewise Announce First Annual Excellence in College Counseling Award Recipient
7. American Psychiatric Nurses Association Opens Call for Abstracts for 2020 APNA Annual Conference
8. Hospice of Westchester Hosts 18th Annual “Tree of Life” Reception
9. Westchester County Hospices Host 10th Annual Veterans Breakfast
10. Fifth Annual Veteran's Day of Care at Britten Periodontics & Implant Dentistry
11. Millions of Retirees Spend $5,000 Annually on Medicare Premiums According to Survey By The Senior Citizens League
Post Your Comments:
(Date:7/2/2020)... ... 2020 , ... ScripHessco has announced the release of their ... migraines to anxiety to fibromyalgia, chiropractors have proven experience in providing treatment methods ... from physician recommendations on WebMD, US News, and Advanced Houston Chiropractors, the graphic ...
(Date:7/1/2020)... ... July 01, 2020 , ... The final ... Awards® is Tuesday, July 28. , The International Business Awards are ... the competition attracted more than 4,000 nominations from organizations in more than 70 ...
(Date:6/28/2020)... ... 26, 2020 , ... Mediaplanet is proud to announce the ... providers, advocates, and scientists to spread awareness of chronic lung disease as well ... , More than 35 million Americans live with a chronic lung ...
Breaking Medicine Technology:
(Date:7/1/2020)... ... July 01, 2020 , ... Psilera Bioscience ... psychedelics and analogues, announces its core executive team. The co-founders Drs. Jackie Salm ... novel formulations, and as distinguished researchers within the cannabis industry. They are joined ...
(Date:6/28/2020)... , ... June 26, 2020 , ... ... mission is to provide high-quality, intensive education and training that prepares graduates for ... Williams as new member of the Board of Trustees. , Ms. Williams currently ...
(Date:6/28/2020)... ... ... The secret of surviving a pandemic with one’s sanity intact does not lie in ... first product to disappear off the shelves when the COVID-19 crisis began. The idea ... to venture out, the longer you can “survive”. However, does all this doomsday-like preparation ...
(Date:6/25/2020)... ... ... Denials Management, Inc. has just published The Health Insurance Appeals Guide to inform ... mental health and substance use disorder (MH/SUD) treatment services. It was written by leading ... steps in the appeals process. Complimentary copies of the Guide can be ...
(Date:6/24/2020)... ... June 24, 2020 , ... ... management, today announced that Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s ... goals within the framework of value-based care. Use of Population Care is benefitting ...
Breaking Medicine News(10 mins):